These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: A follow-up survey. Sivam A; Tankersley M; Ann Allergy Asthma Immunol; 2019 Jun; 122(6):623-629.e2. PubMed ID: 30946915 [TBL] [Abstract][Full Text] [Related]
7. Management of the polyallergic patient with allergy immunotherapy: a practice-based approach. Demoly P; Passalacqua G; Pfaar O; Sastre J; Wahn U Allergy Asthma Clin Immunol; 2016; 12():2. PubMed ID: 26759555 [TBL] [Abstract][Full Text] [Related]
8. Differences and similarities between sublingual immunotherapy of allergy and oral tolerance. Moingeon P; Mascarell L Semin Immunol; 2017 Apr; 30():52-60. PubMed ID: 28760498 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma. Hesse L; Nawijn MC Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043 [TBL] [Abstract][Full Text] [Related]
10. Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy. Wahn U; Calderon MA; Demoly P Expert Rev Clin Immunol; 2017 Mar; 13(3):283-289. PubMed ID: 28033731 [TBL] [Abstract][Full Text] [Related]
11. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. Calderón MA; Cox L; Casale TB; Moingeon P; Demoly P J Allergy Clin Immunol; 2012 Apr; 129(4):929-34. PubMed ID: 22244595 [TBL] [Abstract][Full Text] [Related]
12. Ranking in importance of allergen extract characteristics for sublingual immunotherapy by Italian specialists. Canonica GW; Passalacqua G; Incorvaia C; Cadario G; Fiocchi A; Senna G; Rossi O; Romano A; Scala E; Romano C; Ingrassia A; Zambito M; Dell'Albani I; Frati F Allergy Asthma Proc; 2014; 35(1):43-6. PubMed ID: 24433596 [TBL] [Abstract][Full Text] [Related]
13. Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient. Nelson HS Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1443-1451. PubMed ID: 27687128 [TBL] [Abstract][Full Text] [Related]
14. Management of polysensitized patient: from molecular diagnostics to biomolecular immunotherapy. Ciprandi G; Incorvaia C; Frati F; Expert Rev Clin Immunol; 2015; 11(9):973-6. PubMed ID: 26144241 [TBL] [Abstract][Full Text] [Related]
16. To mix or not to mix in allergy immunotherapy vaccines. Nelson HS Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):583-589. PubMed ID: 34475330 [TBL] [Abstract][Full Text] [Related]
17. Understanding differences in allergen immunotherapy products and practices in North America and Europe. Mahler V; Esch RE; Kleine-Tebbe J; Lavery WJ; Plunkett G; Vieths S; Bernstein DI J Allergy Clin Immunol; 2019 Mar; 143(3):813-828. PubMed ID: 30850069 [TBL] [Abstract][Full Text] [Related]
19. Selection of patients for sublingual versus subcutaneous immunotherapy. Larenas Linnemann DE; Blaiss MS Immunotherapy; 2014; 6(7):871-84. PubMed ID: 25290418 [TBL] [Abstract][Full Text] [Related]
20. Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North America. Moingeon P; Cox L Expert Rev Clin Immunol; 2016 Jun; 12(6):617-23. PubMed ID: 26813047 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]